Aronia melanocarpa fruit extract exhibits anti-inflammatory activity in human aortic endothelial cells by D. Zapolska-Downar et al.
ORIGINAL CONTRIBUTION
Aronia melanocarpa fruit extract exhibits anti-inflammatory
activity in human aortic endothelial cells
D. Zapolska-Downar • D. Bryk • M. Małecki •
K. Hajdukiewicz • D. Sitkiewicz
Received: 6 April 2011 / Accepted: 3 August 2011 / Published online: 24 August 2011
 The Author(s) 2011. This article is published with open access at Springerlink.com
Abstract
Background Altered expression of cell adhesion mole-
cules (CAMs) has been implicated in a variety of chronic
inflammatory conditions, including atherosclerosis. Regu-
lation of adhesion molecule expression by specific redox-
sensitive mechanisms has been reported. Additionally, it
has been observed that the extract of Aronia melanocarpa
(A. Melanocarpa) fruits, rich in polyphenols, exhibits
potent anti-oxidant properties and displays cardioprotective
activity.
Methods and results Human aortic endothelial cells
(HAECs) were pretreated with various concentrations
(primarily 50 lg/mL) of Aronia Melanocarpa fruit extract
prior to treatment with TNFa (10 ng/mL) for various
periods of time. The surface protein and mRNA expression
of ICAM-1 and VCAM-1 were determined using flow
cytometry and real-time RT-PCR, respectively. Adhesion
of peripheral blood mononuclear leucocytes (PBMLs) to
TNFa-treated HAECs was evaluated by an adhesion
assay. Activation of NF-jB was evaluated by measuring
NF-jB p65 phosphorylation using flow cytometry. ROS
production was determined by reduction in fluorescent
20,70-dichlorofluorescein diacetate (DCFH-DA). Tested
A. Melanocarpa extract significantly inhibited the expres-
sion of ICAM-1 and VCAM-1, attenuated the phosphory-
lation of NF-jB p65 and decreased intracellular ROS
production in TNFa-treated HAECs.
Conclusion We conclude that A. Melanocarpa fruit
extract exhibits anti-inflammatory effects in HAECs by
inhibiting the expression of endothelial CAMs, activation
of NF-jB and production of ROS.
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Introduction
Vascular inflammation is a primary event in the patho-
genesis of atherosclerosis [1]. Monocytes and lymphocytes
dominate in the early atheromatous plaque, and their
effector molecules accelerate plaque progression. Further-
more, inflammation can elicit acute coronary syndromes.
The vascular inflammatory reaction is mediated by com-
plex interactions between the circulating leucocytes and
vascular cells (e.g., endothelial cells and smooth muscle
cells). Vascular cells regulate the inflammatory process
through the expression of adhesion molecules, cytokines,
chemokines and growth factors. In healthy blood vessels,
the endothelial cells do not adhere to the cellular constit-
uents of the blood. Some adhesive interactions between
circulating leucocytes and endothelial cells are modified by
the expression of cell adhesion molecules (CAMs). Various
adhesion molecules have been identified on endothelial
cells, including intercellular adhesion molecule-1 (ICAM-1)
and vascular cell adhesion molecule-1 (VCAM-1) [2].
These molecules are up-regulated in the vascular endo-
thelium in response to inflammatory stimuli, including pro-
inflammatory cytokines, such as tumour necrosis factor-a
(TNFa) and interleukin (IL)-1, which are commonly found
in atherosclerotic lesions. Over-expression of ICAM-1 and
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VCAM-1 is a common feature of the atherosclerotic
process.
Regulation of ICAM-1 and VCAM-1 expression occurs
at the transcription level and is mediated, at least in part, by
nuclear factor-jB (NF-jB). This transcription factor plays
an important role in the development of inflammatory
responses by up-regulating the expression of many
inflammatory mediators [3]. In non-stimulated cells, NF-
jB is mostly present in association with its inhibitory
molecules (IjB). Upon the stimulation of endothelial cells
by inflammatory stimuli, IjB becomes phosphorylated,
permitting NF-jB to translocate into the nucleus where it
binds to the promoter regions of inflammatory target genes,
including ICAM-1 and VCAM-1. Previous studies have
indicated that this transcription factor may play an
important role in the pathogenesis of atherosclerosis. It has
been suggested that NF-jB is a redox-sensitive transcrip-
tion factor because reactive oxygen species (ROS) may
regulate its activity [4].
Aronia Melanocarpa (also known as black chokeberry)
is a shrub of the Rosaceae family and originates from North
America [5]. The fruits of A. Melanocarpa have tradi-
tionally been used in North American folk medicine. In the
20th century, the chokeberry was introduced in the Soviet
Union and Eastern Europe and has been cultivated there
since then mainly for the production of juice, jam, wine and
natural food colourants. Aronia Melanocarpa fruits have a
greater content of phenolic constituents than most other
blackberries. These include anthocyanins, procyanidins and
phenolic acids [6, 7].
The high content and composition of the phenolic con-
stituents of A. Melanocarpa seem to be responsible for the
wide range of the fruit’s potential medicinal and thera-
peutic effects. It has been demonstrated that chokeberry
extract or juice possesses anti-oxidative, anti-viral, anti-
mutagenic, anti-cancer hepatoprotective, anti-inflamma-
tory, gastroprotective or anti-diabetic activities [5–8]. Most
of the beneficial activity of A Melanocarpa products is
probably due to the high anti-oxidative activity of their
polyphenols, especially anthocyanins. Aronia berries pos-
sess the highest anti-oxidant capacity among berries and
other fruits investigated to date.
Chokeberry fruit derivatives can also have a beneficial
effect on several risk factors for cardiovascular disease.
The lipid-lowering effect of Aronia fruit juice has been
demonstrated in animal and human studies [9, 10]. In the
animal model, chokeberry anthocyanins decrease lipid
peroxidation [11]. Aronia products might be useful in the
prevention and control of diabetes mellitus [12] and in the
treatment of obesity disorders [13]. Moreover, chokeberry
extract has been shown to reduce blood pressure in patients
with metabolic syndrome [8] and in patients after myo-
cardial infarction [14]. Other effects studied include
enhanced reduction in levels of cardiovascular risk markers,
such as oxy-LDL, CRP, IL-6, sICAM-1, sVCAM-1 or
MCP-1, in patients after myocardial infarction [14, 15].
Anti-platelet effects [16] as well as vasoactive and
vasoprotective properties in porcine coronary arteries
have also been observed [17, 18]. In vitro studies have
demonstrated that the A. Melanocarpa fruit extract inhibits
7b-hydroxycholesterol-induced apoptosis of endothelial
cells [19].
In this study, we have examined the hypothesis that
commercial extract from A. Melanocarpa fruits can inhibit
the cytokine-induced endothelial adhesiveness to periphe-
ral blood mononuclear leucocytes and the expression of
adhesion molecules (ICAM-1 and VCAM-1) in endothelial
cells. In addition, potential molecular mechanisms associ-
ated with such effects, including ROS production and
NF-jB activation, were studied.
Materials and methods
Materials
EBM-2 basal medium, EGM-2 Bulletkit, foetal bovine
serum (FBS), Hanks’ balanced salt solution (HBSS), tryp-
sin–EDTA and trypsin neutralising solution (TNS) were
obtained from LONZA (Switzerland). 3-(4,5-dimethyl-
thiazol-2yl)-2,5-diphenyltetrazolium bromide (MTT),
dimethyl sulfoxide (DMSO), non-enzymatic cell dissocia-
tion solution, 20,70-bis-2-carboxyethyl-5-(and-6)-carboxy-
fluorescein acetoxymethyl ester (BCECF-AM), pyrrolidine
dithiocarbamate (PTDC), ibuprofen and dexamethasone
were provided by Sigma (St. Louis, MO, USA). Human
recombinant TNFa, Phosflow Buffer I, Phosflow Perm
Buffer III, phycoerythrin (PE)-labelled mouse antibody
against human ICAM-1, VCAM-1, NF-jB p65 and IgG1
(isotype control) were all supplied by Becton Dickinson
(San Diego, CA, USA). 20,70-dichlorofluorescein diacetate
(DCFH-DA) was obtained from Molecular Probes and
Ficoll-Paque from Pharmacia (Sweden). A commercial
extract from A. Melanocarpa fruit (Aronox) was purchased
from Agropharm SA (Poland). This extract contained
approximately 53% of total polyphenols, including 23% of
anthocyanins, 15% of procyanidins and 12% of phenolic
acids (information supplied by the producer). Prior to use,
the extract was dissolved in PBS containing 10% DMSO
(10 mg/mL) and further diluted with culture medium.
Dexamethasone and ibuprofen were dissolved in ethanol and
stored at concentrations of 10 and 100 mmol/L, respec-
tively. PDTC was dissolved in medium to a stock solution
of 10 mmol/L. All reagents were maintained at -20 C,
and further dilutions with culture medium were prepared
before use.
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Cell culture and experimental conditions
Human aortic endothelial cells (HAECs) were purchased
from LONZA and cultured in the endothelial cell growth
medium (EGM-2 Bulletkit = EBM-2 ? growth supple-
ments ? 2% FBS) according to the manufacturer’s
instructions. Cells were maintained at 37 C in 5% CO2 in
a humidified atmosphere and were used for experiments
between passages 3 and 4 (doubling population B 10).
When the HAECs reached confluence, they were rested for
5 h in EBM-2 basal medium supplemented with 10% FBS,
and the cells were pretreated with the A. Melanocarpa
extract (1, 10 or 50 lg/mL) for 2 h. The cells were then
treated with TNFa (10 ng/mL) for the indicated period of
time. Cell viability, as determined by trypan blue exclusion
and MTT assay, were unchanged under all the experi-
mental conditions used.
Measurement of adhesion molecule expression using
flow cytometry
Resting HAECs in 12-well plates were pretreated with the
indicated concentrations of A. Melanocarpa extract for 2 h
and then treated with TNFa (10 ng/mL) for 16 h. The cells
were then detached from the plate surface with a non-
enzymatic cell dissociation solution, centrifuged and
washed in PBS containing 1% FBS and resuspended in
100 lL of the labelling buffer. Subsequently, the cells were
incubated in the dark for 1 h with PE-conjugated mouse
anti-human ICAM-1 and VCAM-1 antibodies. For the
isotype control, cells were treated with PE-conjugated
mouse anti-IgG1 antibody. Next, the cells were washed
with PBS and analysed (10,000 cells per sample) with a
FACSCalibur flow cytometer (Becton Dickinson) using
CellQuest Software. After correcting for non-specific
binding using the isotype control, mean fluorescence
intensity was measured as an indicator of ICAM-1 and
VCAM-1 surface protein expression.
Quantitative real-time RT-PCR for ICAM and VCAM
mRNA analysis
Resting HAECs in 6-well plates were pretreated with
A. Melanocarpa extract (50 lg/mL) for 2 h and then treated
with TNFa (10 ng/mL) for 6 h. To determine the ICAM and
VCAM mRNA levels, quantitative real-time RT-PCR was
performed using a LightCycler system (ABI PRISM 7000
Sequence Detection System, Version 1.1, Applied Biosys-
tems). Total RNA was extracted from approximately
2 9 106 cells by the method of Chomczynski and Sacchi
[20] using the TRIzol reagent (Invitrogen) and reverse
transcribed using the High-Capacity cDNA Reverse Tran-
scription Kit (Applied Biosystems). To amplify the target
genes, appropriate primers were synthesised (Institute of
Biochemistry and Biophysics, Poland). The sequences of the
forward and reverse primers were as follows: h-ICAM1F:
50-CTCATCCGCGTGTGTGTGTG-30; h-ICAM1R: 50-GG
AGGCTGAGGTGGGAGGAT-30; h-VCAM1F: 50-TGGGA
AGATGGTCGTGATCC-30; and h-VCAM1R: 50-GCCT
GTTGGTGCTGCAAGTC-30. The b-actin gene was used as
a reference (housekeeping) gene (forward primer, ActbF:
50-TGAAGTGTGACGTTGACATCC-30 and reverse pri-
mer, ActbR: 50- GCCAGAGCAGTAATCTCCTTC-30).
Reaction mixtures (20 lL) consisted of SYBR Green PCR
Master Mix (Applied Biosystems), the forward and reverse
primers and an aliquot of the reverse-transcribed samples
(cDNA, 2 lL). Negative controls were tested in parallel. The
relative mRNA levels of the studied genes were calculated
by the comparative cycle threshold (CT) method (ABI Prism
7000 SDS Software, Version 1.1, Applied Biosystems).
b-actin mRNA levels measured in the same RNA sample for
the target CT normalisation were used to compute the relative
gene expression ratio.
Cell adhesion assay
Peripheral blood mononuclear leucocytes (PBMLs) were
isolated from the blood of healthy volunteers by density
gradient centrifugation with Ficoll-Paque. The isolated
mononuclear cells were resuspended in a serum-free med-
ium and labelled with 10 lmol/L of BCECF-AM for 1 h at
37 C. Non-fluorescent BCECF-AM is lipophilic, and its
methylester is cleaved intracellularly and becomes a highly
charged fluorescent BCECF that is retained by viable cells.
After the labelling, cells were washed twice with PBS con-
taining 5% FBS and resuspended in the EBM-2 medium at a
density of 5 9 105 cells/mL. Resting HAECs in 24-well
plates were pretreated with A. Melanocarpa extract (50 lg/
mL) for 2 h and then incubated with TNFa (10 ng/mL) for
16 h. Fluorescently labelled PBMLs (2.5 9 105 cells/well)
were then seeded over the HAEC monolayer and incubated
for 1 h at 37 C in 5% CO2. After the incubation, the
mononuclear cell suspension was withdrawn, and the
HAECs were washed twice with PBS to remove non-
adherent cells. The fluorescence intensity of each well was
measured with a fluorescence multi-well reader at excitation
and emission wavelengths of 485 and 530 nm, respectively.
Measurement of NF-jB p65 phosphorylation
Optimal activation of NF-jB requires phosphorylation in the
transactivation domain of p65. NK-jB p65 phosphorylation
was determined using flow cytometry using a specific anti-
body that differentiates between the phosphorylated and
non-phosphorylated version of a given protein, as described
previously [21]. Resting HAECs cultured in 6-well plates
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were pretreated with A. Melanocarpa extract (50 lg/mL) for
2 h and then incubated with TNFa (10 ng/mL) for 45 min.
The cells were then detached with a non-enzymatic cell
dissociation solution and fixed with Phospho Fix Buffer I for
10 min at 37 C. To stain intracellular phospho-p65, fixed
cells were washed in PBS and permeabilised with Phospho
Perm Buffer III on ice for 30 min. Next, cells were resus-
pended in 100 lL of staining buffer (1% FBS and PBS) and
stained with PE-conjugated mouse antibody directed against
human phospho-p65 for 2 h at room temperature in the dark.
For the isotype control, cells were treated with PE-conju-
gated mouse anti-IgG2b j antibody. The cells were then
washed and analysed (10,000 cells per sample) with a
FACSCalibur flow cytometer (Becton Dickinson) using
CellQuest Software. After correcting for non-specific bind-
ing using the isotype control, the mean fluorescence intensity
was measured.
Detection of intracellular reactive oxygen species
(ROS) generation
20,70-dichlorofluorescein diacetate (DCFH-DA) was used to
estimate the intracellular generation of ROS. The dye is a
non-polar compound that readily penetrates cells. Intra-
cellular peroxides, mainly H2O2, oxidise DCFH-DA to a
highly fluorescent compound (20,70-dichlorofluorescein
(DCF)). Resting HAECs cultured in 24-well plates were
pretreated with A. Melanocarpa extract at the indicated
concentrations for 2 h and incubated with 50 lmol/L of
DCFH-DA in HBSS for 50 min. Next, cells were washed
twice with PBS and incubated with TNFa (10 ng/mL) for
1 h, and the plates were then read on a fluorescence plate
reader at excitation and emission wavelengths of 485 and
530 nm, respectively. Data were expressed as percentages
of control values (DCF fluorescence of wells without
A. Melanocarpa extract/TNFa treatment).
Statistical analysis
Results are expressed as means ± SD from the indicated
number of experiments. Comparisons were made using the
Student’s t test. Differences between the experimental groups
were considered to be statistically significant at p \ 0.05.
Results
A. Melanocarpa fruit extract inhibits TNFa-stimulated
ICAM-1 and VCAM-1 expression in HAECs as well
as leucocyte adhesion
As cell adhesion molecules on endothelial cells mediate
leucocyte adhesion to the endothelium during inflammation,
we investigated the effects of A. Melanocarpa extract on
TNFa-induced ICAM-1 and VCAM-1 expression. Our
flow cytometry results demonstrated that resting HAECs
exhibited low levels of surface ICAM-1 and VCAM-1
(Fig. 1). As per previous studies, the treatment of HAECs
with TNFa to mimic inflammatory conditions induced
higher than a 10-fold increase in ICAM-1 and VCAM-1
surface expression. Pretreatment with chokeberry extract
significantly suppressed the TNFa-stimulated expression of
ICAM-1 and VCAM-1 in a dose-dependent manner: at
50 lg/mL, chokeberry extract reduced the levels of
expression by about 35 and 45%, respectively. Treatment
of HAEC with A. Melanocarpa extract alone had no
effect on constitutively expressed levels of ICAM-1 or
VCAM-1.
To understand the mechanism responsible for the inhi-
bition of ICAM-1 and VCAM-1 by A. Melanocarpa
extract, we examined whether this extract blocks TNFa-

















































































Fig. 1 Effect of A. Melanocarpa extract (AME) on TNFa-induced
ICAM-1 (a) and VCAM-1 (b) surface expression on endothelial cells.
HAECs were incubated without (control) or with the indicated
concentration of AME for 2 h and then incubated with TNFa (10 ng/
mL) or TNFa alone for 16 h. Next, cells were stained for ICAM-1 and
VCAM-1 and analysed using flow cytometry. Data are expressed as
mean fluorescence intensity corrected for non-specific binding and are
shown as mean ± SD of 6 separate experiments. **p B 0.01 and
*p B 0.001 as compared to TNFa-treated cells
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Fig. 2, stimulation with TNFa led to a marked increase in
ICAM-1 and VCAM-1 mRNA levels in HAECs. Pre-
treatment with 50 lg/mL chokeberry extract caused a
significant decrease in ICAM-1 and VCAM-1 mRNA
expression (about 57 and 60%, respectively) as compared
to TNFa-treated HAECs. These results indicate that A.
Melanocarpa fruit extract inhibits the transcription of
ICAM-1 and VCAM-1 genes.
We checked the functional importance of the inhibitory
properties of chokeberry fruit extract for the TNFa-induced
expression of ICAM-1 and VCAM-1 by investigating the
adhesion of freshly isolated PBMLs to HAECs. Control
HAECs showed minimal binding to PBMLs, but treatment
with TNFa led to an approximately fourfold increase in
adhesion (Fig. 3). Pretreatment with A. Melanocarpa fruit
extract (50 lg/mL) significantly reduced the adhesion
(about 42%) of PBMLs to TNFa-stimulated HAECs.
A. melanocarpa fruit extract attenuates
the phosphorylation of NF-jB p65 in TNFa-stimulated
HAECs
NF-jB is a potent pro-inflammatory transcription factor,
and activation of NF-jB is a central event in the inflam-
matory response. Optimal activation of NF-jB requires the
phosphorylation of p65. Therefore, to examine whether the
inhibitory effect of chokeberry fruit extract on the TNFa-
induced expression of adhesion molecules is mediated by
this transcription factor, we measured the phosphorylation
of NF-jB p65 using flow cytometry. Incubation of HAECs
with TNFa for 45 min induced the phosphorylation of NF-
jB p65 (Fig. 4). Pretreatment with 50 lg/mL A. Melano-
carpa fruit extract significantly attenuated the phosphory-
lation of NF-jB p65 in TNFa-stimulated HAECs.
A. Melanocarpa fruit extract inhibits intracellular ROS
production
ROS produced by various stimuli contribute to the intra-
cellular signalling pathways associated with the inflam-
matory response, including NF-jB activation [4]. As tested
chokeberry fruit extract inhibited TNFa-induced NF-jB
activation, we therefore examined the effect of A. Mela-
nocarpa fruit extract on TNFa-stimulated ROS production
in HAECs. As shown in Fig. 5, there was an approximately
twofold increase in intracellular ROS generation upon
stimulation of the HAECs with TNFa. Treatment of
endothelial cells with fruit extract prior to incubation with
TNFa significantly inhibited intracellular ROS generation
in a dose-dependent manner. Unstimulated HAECs (no
added TNFa) treated with A. Melanocarpa extract (50 lg/
mL) showed significantly decreased DCF fluorescence, as
compared to non-extract-treated controls (p B 0.001).
Comparison between A. Melanocarpa fruit extract
and a panel of drugs with known anti-inflammatory
and/or anti-oxidant activity in inhibiting the TNF-a-
stimulated expression of ICAM-1 and VCAM-1
In the next step, using the same model of TNFa-stimulated
HAECs, we compared the inhibitory effect of A. Melano-
carpa extract on pro-inflammatory responses in endothelial
cells with those of other drugs with well-known anti-
inflammatory and/or anti-oxidant activities. As shown
above, tested chokeberry extract at a concentration of
50 lg/mL reduced ICAM-1 and VCAM-1 expression by
about 35 and 45%, respectively. Dexamethasone at a






























































Fig. 2 Effects of A Melanocarpa extract (AME) on TNFa-induced
ICAM-1 (a) and VCAM-1 (b) mRNA expression in endothelial cells.
HAECs were incubated without (control) or with AME (50 lg/mL for
2 h and then incubated with TNFa (10 ng/mL) or TNFa only for 6 h.
Total RNA was isolated, and the mRNA levels of ICAM-1 and
VCAM-1 were analysed by quantitative real-time RT-PCR as
described in ‘‘Materials and methods’’. The expression levels of the
control gene were set to 1, and the values are normalised to b-actin.
Data are expressed as a multiple of the control and are shown as
mean ± SD of 7 separate experiments. **p B 0.01 and *p B 0.001
as compared to TNFa-treated cells
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ICAM-1 and VCAM-1 only by approximately 25 and 23%,
respectively (Fig. 6). Both ibuprofen and PDTC showed
similar effects on VCAM-1 expression as A. Melanocarpa
fruit extract. Ibuprofen (1 mmol/L) inhibited TNFa-
induced VCAM-1 expression by approximately 51% and
PDTC (100 lmol/L) by 47%. However, the effect of ibu-
profen and PDTC on ICAM-1 expression was much
smaller than that of tested chokeberry extract. Ibuprofen
reduced TNFa-induced ICAM-1 expression by approxi-
mately 23% and PDTC by 28%.
Discussion
Inflammation plays an important role in atherosclerosis
development and progression as well as in atheromatous
plaque rupture and, thus, in the onset of acute clinical
complications [1]. An early stage in the inflammatory
process is endothelial activation, which is directly
responsible for the recruitment of circulating leucocytes.
This process is self-maintaining and is mediated through
the cell adhesion molecules expressed on the surface of
endothelial cells, including ICAM-1 and VCAM-1 [2].
Pharmacological agents that display an inhibitory effect on
endothelial cell activation should have anti-inflammatory
activity. The tested extract was a commercially available
preparation of chokeberry, which is a condensed source of
polyphenols, especially anthocyanin glycosides.
In the present study, we provide new evidence that the
A. melanocarpa extract, rich in polyphenols, can inhibit the
pro-inflammatory response of endothelial cells. We found
that this chokeberry extract down-regulated TNFa-induced
ICAM-1 and VCAM-1 surface protein expression in a
concentration-dependent manner. In addition, real-time
RT-PCR analysis showed that the suppressive effect of the
A. melanocarpa extract on the expression of surface
endothelial cell adhesion molecules was correlated with
their mRNA levels. Thus, it may be suggested that the
observed effect of the tested extract might be due to its
influence on the mechanisms regulating the transcription of
the genes encoding these molecules.
One of the functional consequences of inhibiting the
surface expression of adhesion molecules should be a
decrease in endothelial adhesive properties for leucocytes.
Indeed, in our study, we showed that preincubation of the
HAECs with A. melanocarpa fruit extract resulted in a
reduction in TNFa-stimulated increased adhesiveness for
PBMLs. Because adhesion is one of the earliest steps in
inflammation and atherosclerosis, leading to the subsequent
migration of blood leucocytes into the sub-endothelial
space, the decrease in the adhesive properties of activated
endothelial cells may be an important mechanism by which
A. Melanocarpa fruit exerts its anti-inflammatory and anti-
atherogenic effects.
The NF-jB redox-sensitive transcription factor plays a







































Fig. 3 Effect of
A. Melanocarpa extract (AME)
on TNFa-induced adhesiveness
of endothelial cells for
peripheral blood mononuclear
leucocytes. HAECs were
incubated without (control) or
with AME (50 lg/mL) for 2 h
and then incubated with TNFa
(10 ng/mL) or TNFa only for
16 h. Peripheral blood
mononuclear leucocytes
(PBMNLs) were labelled with
BCECF-AM, and binding to the
endothelial cells was quantified
as described in ‘‘Materials and
methods’’. a Photographic view
of PBMNLs adhered to HAECs.
(a) control, (b) TNFa and
(c) AME ? TNFa. b Data are
summarised and plotted. Values
are expressed as % of control
(set at 100%) and are shown as
mean ± SD of 5 separate
experiments, each performed in
triplicate. *p B 0.001 as
compared to TNFa-treated cells
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expression [3]. Its role in the pathogenesis of atheroscle-
rosis has been indicated by studies showing that its active
form is present in atherosclerotic lesions [22], and the
intensification of immunoreactivity for active form of NF-
jB is more pronounced in patients with unstable ischaemic
disease as compared with its stable form [23]. The optimal
activation of NF-jB, allowing its binding to the appropriate
promoter regions, requires phosphorylation in the transac-
tivation domain of the p65 protein. Thus, we decided to
evaluate the effects of the investigated extract on NF-jB
activation by measuring the extent of p65 phosphorylation
using specific antibodies that recognise only the phos-
phorylated form. In the present study, we found that TNFa
induced higher levels of NF-jB phosphorylation that could
be decreased in HAECs when pretreated with the poly-
phenol-rich A. melanocarpa extract. These results suggest
that the anti-inflammatory properties of this extract in vitro
are mediated, at least in part, by the inhibition of NF-jB
activation.
Several studies have indicated that ROS are implicated
in the activation of NF-jB. [4]. It is postulated that ROS
interfere with signalling pathways, which leads to phos-
phorylation and subsequent IjB degradation. Our study has
shown that the chokeberry extract lowers the intracellular
ROS production not only in cells exposed to TNFa but also
in quiescent ones.
Based on the results of our study, we assume that the
inhibitory effect of A. melanocarpa fruit extract on ICAM-1
and VCAM-1 expression and NF-jB activation may be due
to anti-oxidant properties.
Finally, the inhibitory effects of A. Melanocarpa fruit
extract were compared with those of other drugs with well-
known anti-inflammatory and/or anti-oxidant activities,
such as dexamethasone, ibuprofen and PDTC. Studies
conducted in the same conditions demonstrated that the
extent of the inhibitory effect of the tested chokeberry
extract on the TNFa-induced VCAM-1 expression was
similar to that of ibuprofen and PDTC. The effect of
A. Melanocarpa extract on TNFa-stimulated ICAM
expression was much greater than that observed for ibu-
profen and PDTC, while dexamethasone reduced TNFa-
induced ICAM-1 and VCAM-1 expression to only a minor
extent despite its strong anti-inflammatory activity. The
differences observed are most likely due to varying
mechanisms of action. The principal mechanism of action



































Fig. 4 Effect of A. Melanocarpa extract (AME) on TNFa-induced
phosphorylation of NF-jB. HAECs were incubated without (control)
or with AME (50 lg/mL) for 2 h and then incubated with TNFa
(10 ng/mL) or TNFa only for 45 min. a Data are expressed as mean
fluorescence intensity corrected for non-specific binding and are
shown as mean ± SD of 8 separate experiments. *p B 0.001 as
compared to TNFa-treated cells. b Representative histograms of
typical experiments showing the effect of AME on TNFa-stimulated







































Fig. 5 Effect of A. Melanocarpa extract (AME) on TNFa-induced
intracellular ROS generation in endothelial cells. HAECs were
incubated without (control) or with AME (50 lg/mL) for 2 h, and
the cells were then loaded with DCFH DA (50 lmol/L) for 45 min
and were treated with TNFa (10 ng/mL) for 1 h. The conversion of
DCFH to DCF was measured as described in ‘‘Materials and
methods’’. Values are expressed as % of control DCF fluorescence
(set at 100%) and are shown as mean ± SD of 10 separate
experiments. *p B 0.001 as compared to the TNFa-treated cells;
#p B 0.001 as compared to the control
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glucocorticoid receptor (GR) (transrepression), which
occurs via different mechanisms [24]. The most intensively
investigated mechanism is the ability of the GR to inhibit
the activity of other transcription factors through molecular
interactions known as tethering. The transcription factors to
which GR is tethered include NF-jB and activator protein-
1 (AP-1), another transcription factor which is activated by
most agents that activate NF-jB [25]. The activation of
both NF-jB and AP-1 is in most cases dependent on the
production of ROS [26]. We observed a minor effect on the
TNFa-stimulated expression of both ICAM-1 and VCAM-
1 that may be caused by the fact that the drug simulta-
neously enhances the production of ROS in endothelial
cells [27]. PDTC is a known inhibitor of NF-jB activation
[28] and may exert its effect via binding to the superoxide
anion, thus reducing the formation of H2O2, which seems
to be the principal NF-jB activator [4]. The inhibitory
effects of PDTC on VCAM-1 expression, which were
much stronger than those exerted on ICAM-1 expression,
have also been observed by other authors; these effects
result probably from the fact that oxidative stress–depen-
dent NF-jB activation is crucial for the stimulation of
VCAM-1 expression but is not the only factor required for
ICAM-1 induction [29, 30]. The effect of ibuprofen was
similar to that of PDTC, which is consistent with other
reports [31]. The available literature suggests that ibupro-
fen inhibits the activation of NF-jB by blocking the
activity of phosphorylating kinases IjB [32]. Despite a lack
of direct evidence, the similar effects of ibuprofen and
PDTC on TNFa-stimulated VCAM-1 expression are
thought to be due to the fact that both ibuprofen and PDTC
are scavengers of hydroxyl radicals [33].
A. Melanocarpa fruit extract contains 53% polyphenols of
which the majority (23%) consist of anthocyanins, mainly
cyanidin-3-glucoside. There are conflicting reports in the
literature regarding the effects of anthocyanins on the TNFa-
stimulated expression of ICAM-1 and VCAM-1. Studies
conducted by Nizamutdinov et al. [34] demonstrated that
anthocyanins from black soybean seed coats, mainly cyani-
din-3-glucoside, delphinidin-3-glucoside and petunidin-3-
glucoside, inhibited TNFa-induced VCAM-1 but not ICAM-
1 expression. Other studies have also shown that the same
anthocyanins inhibited both TNFa-induced VCAM-1 and
ICAM-1 expression through an NF-jB-dependent pathway
[35]. A. Melanocarpa extract also contains 12% phenolic
acids. Recent studies have shown that caffeic acid also
reduces TNFa-induced ICAM-1 and VCAM-1 by inhibiting
NF-jB activation [36]. Despite the fact that all tested sub-
stances inhibited the activation of NF-jB, it was the tested
chokeberry extract that had the greatest effect on the pro-
inflammatory activation of endothelial cells.
The concentration range of the tested extract (1–50 lg/
mL) was similar to that used in other studies [16]. Similar
concentrations have been applied for other plant extracts
rich in polyphenols [37, 38]. The A. melanocarpa berry
extract used in this study at 50 lg/mL contained approxi-
mately 25 lmol/L of anthocyanin glycosides and 50 lmol/
L of total polyphenols. Similar concentrations were adop-
ted in vitro studies employing single polyphenols, such as
cyanidin glycoside (1–100 lmol/L) or chlorogenic acid
(25–50 lmol/L) [39, 40]. However, it is most likely that
the achievement of such levels in the blood is not possible.
Early studies show that anthocyanin glycosides are absor-
bed from both the stomach and the small intestine without
modification, and their intact forms are detected in both
plasma and urine. Depending on the anthocyanin glycoside
content in the consumed product, the detected serum levels
ranged from 100 to 500 nmol/L [41, 42]. Thus, a typical
dose of commercial A. melanocarpa fruit extract (3 tablets;
45 mg anthocyanins) would not reach the levels of the
extract used in our study [6]. However, no studies have





































































Fig. 6 Comparison between A. Melanocarpa extract (AME) and the
panel of anti-inflammatory and/or anti-oxidant drugs on the expres-
sion of ICAM-1 (a) and VCAM-1 (b) in HAECs stimulated with
TNF. HAECs were pretreated with dexamethasone (Dex) (100 lmol/
L), ibuprofen (Ibu)(1 mmol/L), PDTC (100 lmol/L) and AME
extract (50 lg/mL) for 2 h and then incubated with TNFa (10 ng/
mL) or TNFa only for 16 h. Next, the cells were stained for ICAM-1
and VCAM-1 and analysed using flow cytometry. Data are expressed
as mean fluorescence intensity corrected for non-specific binding and
are shown as mean ± SD of 6 separate experiments. *p B 0.001 as
compared to TNFa-treated cells
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of anthocyanins or other components from the specific
chokeberry preparation used in this study. Additionally, it
should be noted that due to the time constraints of the in
vitro tests, the reaction threshold is usually obtained at
higher concentrations. Moreover, long-term administration
of such an extract may lead to the accumulation of active
compounds and, thus, to a longer-lasting exposure of cells
and the possibility of obtaining the same effect at lower
doses. Garcia-Alonso et al. [43] have reported that in spite
of the low concentration of anthocyanins found in plasma
after the consumption of red wine extract (12 g), an
increase in the anti-oxidant capacity and a decrease in
circulating MCP-1 levels in the plasma were also observed.
In summary, we found that the A. melanocarpa extract,
which is rich in polyphenols, can reduce TNFa-induced
ICAM-1 and VCAM-1 protein and mRNA expression in
HAECs as well as inhibit the TNFa-induced increase in
mononuclear leucocyte adhesion to HAECs. A. melano-
carpa extract also attenuated the TNFa-induced activation
of NF-jB and suppressed the production of ROS in
HAECs. These findings may provide new insights into
understanding the molecular mechanisms underlying the
beneficial effects of A. melanocarpa fruits on endothelial
cells and imply that these berries or other products rich in
anthocyanidins may have therapeutic potential in the pre-
vention of atherosclerosis and other pathological events
involving leucocyte adhesion.
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